FindTrial
Sign In

Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019368
Enrollment
Unknown
Registered
2018-11-07
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction, contrast-induced nephropathy

Interventions

CIN:No
Non-CIN:No

Sponsors

Zhongda Hospital of Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) aged=18 years old; (2) the diagnosis was confirmed as STEMI combined with emergency PCI.

Exclusion criteria

Exclusion criteria: (1) end-stage renal disease requiring dialysis; (2) allergy to contrast agent; (3) intravascular administration of contrast medium within 2 weeks; (4) autoimmune diseases; (5) malignant tumor; (6) infectious diseases; and (7) cardiac shock.

Design outcomes

Primary

MeasureTime frame
Cyt C;Scr;—

Countries

China

Contacts

Public ContactChengchun Tang

Zhongda Hospital of Southeast University

tangchengchun@hotmail.com+86 13914705570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026